J. Dudler

发表

The Global Spine Care Initiative: World Spine Care executive summary on reducing spine-related disability in low- and middle-income communities

Chung Chek Wong, F. Blyth, M. Nordin, 2018, European Spine Journal.

The Effect of Reduced or Withdrawn Etanercept-methotrexate Therapy on Patient-reported Outcomes in Patients with Early Rheumatoid Arthritis

S. Kotak, D. Veale, P. Wiland, 2016, The Journal of Rheumatology.

Bilateral primary brucellar psoas abscess.

F. Balagué, J. Dudler, M. Waldburger, 1994, British journal of rheumatology.

Rheumatoid arthritis - treatment 180. Utility of Body Weight Classified Low-Dose Leflunomide in Japanese Rheumatoid Arthritis

Stanley B. Cohen, D. Symmons, M. Dougados, 2011 .

Can one or two high doses of oral vitamin D3 correct insufficiency in a non-supplemented rheumatologic population?

D. Hans, M. Krieg, O. Lamy, 2013, Osteoporosis International.

High prevalence of hypovitaminosis D in a Swiss rheumatology outpatient population.

D. Hans, M. Krieg, A. So, 2011, Swiss medical weekly.

The Dermatologists' Role in Managing Psoriatic Arthritis: Results of a Swiss Delphi Exercise Intended to Improve Collaboration with Rheumatologists

C. Conrad, A. Navarini, C. Gabay, 2015, Dermatology.

Screening for tuberculosis infection before initiation of anti-TNF- a therapy

C. Beglinger, F. Seibold, C. Mottet, 2007 .

What is the rational diagnostic approach to spinal disorders?

F. Balagué, J. Dudler, 2002, Best practice & research. Clinical rheumatology.

Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?

D. Courvoisier, U. Walker, C. Gabay, 2009, Annals of the rheumatic diseases.

Morphometric vertebral assessments via the use of dual X-ray absorptiometry for the evaluation of radiographic damage in ankylosing spondylitis: a pilot study.

D. Hans, M. Krieg, O. Lamy, 2014, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

SAT0692 Breastfeeding is not associated with anti-citrullinated antibodies development in individuals at risk for rheumatoid arthritis

U. Walker, P. Roux‐Lombard, C. Gabay, 2018, Saturday, 16 JUNE 2018.

OP0166 Antibodies Against Periodontal Pathogens are not Associated with Joint Swelling or Autoimmunity Associated with RA in a Cohort of Healthy Individuals at Increased Risk of Rheumatoid Arthritis

U. Walker, C. Gabay, N. Bostanci, 2015 .

The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis

D. Courvoisier, U. Walker, M. Mahler, 2017, Clinical Rheumatology.

Use of abatacept in rheumatoid arthritis.

A. Tyndall, P. Zufferey, D. Kyburz, 2012, Swiss medical weekly.

CPPD crystal deposition disease in patients with rheumatoid arthritis

A. So, P. Varisco, J. Dudler, 2006, Clinical Rheumatology.

Low-back pain in children

M. Nordin, F. Balagué, J. Dudler, 2003, The Lancet.

Screening for tuberculosis infection before the initiation of an anti-TNF-alpha therapy.

C. Beglinger, F. Seibold, C. Mottet, 2007, Swiss medical weekly.

Clinical and Epidemiological Research

U. Walker, C. Gabay, D. Kyburz, 2022 .

EULAR portfolio for Rheumatology training: a EULAR School of Rheumatology initiative

S. Ramiro, J. D. da Silva, L. Falzon, 2021, RMD Open.

Effect of interleukin 17 on proteoglycan degradation in murine knee joints

N. Busso, J. Dudler, M. Lotz, 2000, Annals of the rheumatic diseases.

Efficacy, Safety and Mucosal Healing of Methotrexate in a Large Longitudinal Cohort of Inflammatory Bowel Disease Patients

V. Pittet, P. Michetti, J. Dudler, 2017, Digestion.

Leg pain due to bilateral focal recurrent myositis in a hemodialysis patient.

J. Lobrinus, N. Theumann, A. So, 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Methotrexate as an alternative therapy for chronic calcium pyrophosphate deposition disease: an exploratory analysis.

P. Guerne, A. Finckh, J. Dudler, 2007, Arthritis and rheumatism.

Disease activity in rheumatoid arthritis patients at initiation of biologic agents and 1 year of treatment: results from the Swiss SCQM registry.

P. Zufferey, A. Finckh, J. Dudler, 2013, Joint, bone, spine : revue du rhumatisme.

Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapy.

D. Kyburz, A. Rubbert-Roth, P. Villiger, 2022, Rheumatology.

Swiss consensus statement: Recommendations for optimising re-treatment with MabThera (rituximab) in rheumatoid arthritis.

U. Schmiedel, U. Walker, D. Kyburz, 2010, Swiss medical weekly.

Aseptic psoas pyomyositis and erosive discitis in a case of calcium pyrophosphate crystal deposition disease.

J. Dudler, J. Gerster, R. Stucki, 2000, Rheumatology.

Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides.

D. Speiser, P. Romero, C. Jandus, 2008, Arthritis and rheumatism.

B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents.

C. Gabay, D. Kyburz, A. Finckh, 2007, Arthritis and rheumatism.

Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort.

K. Rufibach, M. Dougados, A. Boonen, 2013, Arthritis and rheumatism.

Steroids for LBP - from rationale to inconvenient truth.

F. Balagué, J. Dudler, V. Piguet, 2012, Swiss medical weekly.

Polyarthritis and pitting oedema

A. So, J. Dudler, J. Gerster, 1999, Annals of the rheumatic diseases.

John Axford Polyarthritis and pitting oedema

A. So, J. Dudler, J. Gerster, 1999 .

Eczematous drug eruption after infliximab

E. Laffitte, J. Dudler, R. Panizzon, 2004, The British journal of dermatology.

Fear of impending fractures: when to refer? A case-based review

F. Balagué, J. Dudler, C. Kronisch, 2015, Clinical Rheumatology.

Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients.

C. Gabay, D. Kyburz, A. Finckh, 2010, Joint, bone, spine : revue du rhumatisme.

Cranial neuropathies in granulomatosis with polyangiitis (Wegener's): a case-based review

J. Dudler, S. Revaz, A. Söderström, 2015, Clinical Rheumatology.

Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis

D. Courvoisier, U. Walker, M. Mahler, 2017, Rheumatology.

Safety and efficacy of ocrelizumab in combination with methotrexate in MTX-naive subjects with rheumatoid arthritis: the phase III FILM trial

C. Zerbini, J. Gómez-Reino, W. Stohl, 2012, Annals of the rheumatic diseases.

The Global Spine Care Initiative: model of care and implementation

Chung Chek Wong, F. Blyth, M. Nordin, 2018, European Spine Journal.

Tenosynovitis of the Hands Caused by Mycobacterium kansasii in a patient with scleroderma.

J. Dudler, B. Duvoisin, J. Gerster, 2004, The Journal of rheumatology.

Terminal phalangeal osteosclerosis and rheumatoid arthritis

J. Dudler, B. Aubry-Rozier, Michael Currat, 2011, Canadian Medical Association Journal.

Rat bite fever without fever

A. So, J. Dudler, O. Dubuis, 2003, Annals of the rheumatic diseases.

Fever and musculoskeletal symptoms in an adult: differential diagnosis and management.

J. Dudler, A. Kai-Lik So, S. Revaz, 2006, Best practice & research. Clinical rheumatology.

Intermediate Uveitis in an HLA-B27-Positive Patient Treated with Upadacitinib.

A. Schalenbourg, J. Dudler, Y. Guex-Crosier, 2022, Klinische Monatsblatter fur Augenheilkunde.

Change from subcutaneous to intravenous abatacept and back in patients with rheumatoid arthritis as simulation of a vacation: a prospective phase IV, open-label trial (A-BREAK)

J. von Kempis, R. Mueller, J. Dudler, 2016, Arthritis Research & Therapy.

Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT)

J. Reginster, K. Pavelka, J. Dudler, 2017, Annals of the rheumatic diseases.

Biologics in rheumatoid arthritis--recommendations for Swiss practice.

B. Michel, P. Villiger, J. Dudler, 2011, Swiss medical weekly.

Physical activity and energy expenditure in rheumatoid arthritis patients and matched controls.

F. Bastardot, P. Vollenweider, I. Guessous, 2012, Rheumatology.

Dr. Wiland, et al, reply

S. Kotak, D. Veale, P. Wiland, 2017, The Journal of Rheumatology.

The Global Spine Care Initiative: methodology, contributors, and disclosures

Chung Chek Wong, F. Blyth, M. Nordin, 2018, European Spine Journal.

The Global Spine Care Initiative: a systematic review for the assessment of spine-related complaints in populations with limited resources and in low- and middle-income communities

M. Nordin, R. Chou, E. Hurwitz, 2018, European Spine Journal.

Shrinking Lung Syndrome Successfully Treated with Rituximab and Cyclophosphamide

F. Spertini, J. Fitting, J. Dudler, 2012, Respiration.

THU0174 Drug retention of tofacitinib versus biologic antirheumatic agents in rheumatoid arthritis: observational data from the swiss scqm registry

C. Gabay, P. Zufferey, D. Kyburz, 2017 .

An overview of conservative treatment for lower back pain

F. Balagué, J. Dudler, 2011 .

AB0364 A Novel Approach for Rheumatoid Arthritis: Results of The Ongoing Clinical Trials with The Fully Human Immunocytokine Dekavil (F8-IL10)

P. Sarzi-Puttini, R. Caporali, L. Bazzichi, 2016 .

Perceived Behavioral Changes in Early Multiple Sclerosis

J. Annoni, L. Bruggimann, M. Schluep, 2007, Behavioural neurology.

Use of abatacept in rheumatoid arthritis Recommendations based on current evidence

A. Tyndall, P. Zufferey, D. Kyburz, 2012 .

Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion.

D. Courvoisier, U. Walker, J. von Kempis, 2011, Rheumatology.

2019 EULAR points to consider for the assessment of competences in rheumatology specialty training

M. Dougados, A. Iagnocco, G. Burmester, 2020, Annals of the Rheumatic Diseases.

Bone non-union after osteotomy in patients treated with methotrexate.

J. Dudler, J. Gerster, R. Bossy, 1999, The Journal of rheumatology.

Points to consider: EULAR–UEMS standards for the training of European rheumatologists

A. Iagnocco, F. Buttgereit, S. Ramiro, 2023, Annals of the Rheumatic Diseases.

Prescribing Conservative Treatment for Low Back Pain

F. Balagué, J. Dudler, 2010 .

The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial.

F. Pieruzzi, B. Rovin, V. Strand, 2023, The Lancet. Rheumatology.

RAISE - rheumatoid arthritis independent Swiss treatment expectations and outcome: results for the abatacept subpopulation.

J. Dudler, A. Forster, Roland D. Tuerk, 2013, Swiss medical weekly.

[Arthrocentesis and joint infiltration].

D. Gachoud, J. Dudler, M. Monti, 2008, Revue medicale suisse.

Cellulitis caused by Capnocytophaga cynodegmi associated with etanercept treatment in a patient with rheumatoid arthritis

J. Dudler, J. Gerster, 2004, Clinical Rheumatology.